4.6 Article

Induction of the glucocorticoid-induced leucine zipper gene limits the efficacy of dendritic cell vaccines

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Improving vaccines by targeting antigens to dendritic cells

Ken Shortman et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2009)

Review Biochemistry & Molecular Biology

Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action

Emira Ayroldi et al.

FASEB JOURNAL (2009)

Article Gastroenterology & Hepatology

Glucocorticoid-Induced Leucine Zipper Is Protective in Th1-Mediated Models of Colitis

Lorenza Cannarile et al.

GASTROENTEROLOGY (2009)

Review Biotechnology & Applied Microbiology

Dendritic Cell-Based Cancer Gene Therapy

Evelien L. J. M. Smits et al.

HUMAN GENE THERAPY (2009)

Article Oncology

Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia

M. Palma et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)

Article Endocrinology & Metabolism

Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma

C. Papewalis et al.

HORMONE AND METABOLIC RESEARCH (2008)

Review Immunology

Cancer immunotherapy by dendritic cells

Cornelis J. M. Melief

IMMUNITY (2008)

Article Oncology

Dendritic cell vaccines for the treatment of prostate cancer

Todd J. Lehrfeld et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)

Article Biotechnology & Applied Microbiology

Chemokine gene modification of human dendritic cell-based tumor vaccines using a recombinant adenoviral vector

A Terando et al.

CANCER GENE THERAPY (2004)

Article Immunology

Orphan nuclear receptor Nur77 is involved in caspase-independent macrophage cell death

SO Kim et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2003)